Forbes (October 18)
“Nike dropping Lance Armstrong as a product endorser has begun to (and will continue to result in) a mass exodus of corporate support that will eventually cost the former cycling champion over $150 million in career endorsement earnings potential.” When the USADA’s report of doping was first released, Armstrong’s endorsers stuck with him. That has changed.
Tags: Lance Armstrong, Nike, Product endorsments, USADA
Time (October 11)
The “USADA’s case against Lance Armstrong is compelling.” Time only has one more question for the Tour de France winner. “Why lie about it all these years? In a grueling competition like the Tour de France, in a sport filled with dopers, using stuff like testosterone and EPO is almost understandable. And America forgives users who come clean. Armstrong’s failure to see that is a mystery.”
Tags: Cycling, Doping, Lance Armstrong, Tour de France, U.S., USADA
